ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
147 hedge funds and large institutions have $602M invested in ChemoCentryx, Inc. in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 57 increasing their positions, 38 reducing their positions, and 68 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 38
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less funds holding
Funds holding: 183 → 147 (-36)
48% less call options, than puts
Call options by funds: $34.1M | Put options by funds: $65M
50% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 68
79% less capital invested
Capital invested by funds: $2.82B → $602M (-$2.22B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$71.9M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$20.8M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
+$20M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$12.3M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$11.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$313M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
-$79.3M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$62.6M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$55.8M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$48.2M |
CCXI Hedge Fund Activity: Q2 2021 in Review
147 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q2 2021, worth a combined $602M — down 79% from $2.82B a quarter earlier.
Sellers outnumbered buyers: 68 funds closed out of CCXI and 34 opened new positions — a net loss of 34 holders — while 38 trimmed existing stakes and 57 added.
The largest buyer was State Street, adding an estimated $71.9M. The largest seller was Wellington Management Group, exiting entirely with an estimated $313M sold.
- 147 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q2 2021, down from 183 in Q1 2021.
- Funds reported $602M of ChemoCentryx, Inc. stock for Q2 2021, down 79% quarter-over-quarter.
- 34 funds opened new ChemoCentryx, Inc. positions in Q2 2021 and 68 closed out, a net change of -34 holders.
- The largest ChemoCentryx, Inc. buyer in Q2 2021 was State Street, an estimated $71.9M added.
- The largest ChemoCentryx, Inc. seller in Q2 2021 was Wellington Management Group, an estimated $313M sold.
Based on aggregated 13F filings for Q2 2021.